Yersinia pestis CO92ΔyopH is a potent live, attenuated plague vaccine

Clinical and Vaccine Immunology

Volumn 14, Issue 9, 2007, Pages 1235-1238

  Bubeck, Sarah S ^a   Dube, Peter H ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; PLAGUE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BUBONIC PLAGUE; CONTROLLED STUDY; DRUG POTENCY; EXPERIMENTAL MODEL; FEMALE; GENE DELETION; MOUSE; NONHUMAN; PLAGUE; PNEUMONIC PLAGUE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; YERSINIA PESTIS; YERSINIOSIS;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; FEMALE; MICE; PLAGUE; PLAGUE VACCINE; PROTEIN TYROSINE PHOSPHATASES; VACCINES, ATTENUATED; YERSINIA PESTIS;

EID: 34948904919     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00137-07     Document Type: Article

References (38)

1. Anderson, G. W., Jr., D. G. Heath, C. R. Bolt, S. L. Welkos, and A. M. Friedlander. 1998. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:793-799.
2. Reference deleted.
3. Anisimov, A. P., L. E. Lindler, and G. B. Pier. 2004. Intraspecific diversity of Yersinia pestis. Clin. Microbiol. Rev. 17:434-464.
4. Anonymous. 2005. Plague, Democratic Republic of The Congo. Wkly. Epidemiol. Rec. 80:65.
5. Bertherat, E., K. M. Lamine, P. Formenty, P. Thuier, V. Mondeinge, A. Mitifu, and L. Rahalison. 2005. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge. Med. Trop. (Mars) 65:511-514. (In French.)
6. Bliska, J. B., K. Guan, J. E. Dixon, and S. Falkow. 1991. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc. Natl. Acad. Sci. USA 88:1187-1191.
7. Bubeck, S. S., A. M. Cantwell, and P. H. Dube. 2007. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect. Immun. 75:697-705.
8. Chen, T. H., S. S. Elbert, and D. M. Eisler. 1976. Immunity in plague: protection induced in Cercopithecus aethiops by oral administration of live, attenuated Yersinia pestis. J. Infect. Dis. 133:302-309.
9. Cohen, R. J., and J. L. Stockard. 1967. Pneumonic plague in an untreated plague-vaccinated individual. JAMA 202:365-366.
10. Cornelis, G. R., T. Biot, C. Lambert de Rouvroit, T. Michiels, B. Mulder, C. Sluiters, M. P. Sory, M. Van Bouchaute, and J. C. Vanooteghem. 1989. The Yersinia yop regulon. Mol. Microbiol. 3:1455-1459.
11. Darveau, R. P., W. T. Charnetzky, R. F. Hurlbert, and R. E. Hancock. 1983. Effects of growth temperature, 47-megadalton plasmid, and calcium deficiency on the outer membrane protein porin and lipopolysaccharide composition of Yersinia pestis EV76. Infect. Immun. 42:1092-1101.
12. Doll, J. M., P. S. Zeitz, P. Ettestad, A. L. Bucholtz, T. Davis, and K. Gage. 1994. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am. J. Trop. Med. Hyg. 51:109-114.
13. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677-680.
14. Glynn, A., L. C. Freytag, and J. D. Clements. 2005. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 23:1957-1965.
15. Guiyoule, A., G. Gerbaud, C. Buchrieser, M. Galimand, L. Rahalison, S. Chanteau, P. Courvalin, and E. Carniel. 2001. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7:43-48.
16. Hallett, A. F. 1977. Evaluation of live attenuated plague vaccines in Praomys (Mastomys) natalensis. Infect. Immun. 18:8-13.
17. Heath, D. G., G. W. Anderson, Jr., J. M. Mauro, S. L. Welkos, G. P. Andrews, J. Adamovicz, and A. M. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
18. Hinnebusch, B. J., M. L. Rosso, T. G. Schwan, and E. Carniel. 2002. High-frequency conjugative transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut. Mol. Microbiol. 46:349-354.
19. Jones, S. M., F. Day, A. J. Stagg, and E. D. Williamson. 2000. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19:358-366.
20. Jones, S. M., K. F. Griffin, I. Hodgson, and E. D. Williamson. 2003. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 21:3912-3918.
21. Jones, T., J. J. Adamovicz, S. L. Cyr, C. R. Bolt, N. Bellerose, L. M. Pitt, G. H. Lowell, and D. S. Burt. 2006. Intranasal protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 24:1625-1632.
22. Kerschen, E. J., D. A. Cohen, A. M. Kaplan, and S. C. Straley. 2004. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72:4589-4602.
23. Lathem, W. W., S. D. Crosby, V. L. Miller, and W. E. Goldman. 2005. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc. Natl. Acad. Sci. USA 102:17786-17791.
24. Logsdon, L. K., and J. Mecsas. 2003. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect. Immun. 71:4595-4607.
25. Marshall, J. D., Jr., P. J. Bartelloni, D. C. Cavanaugh, P. J. Kadull, and K. F. Meyer. 1974. Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine. J. Infect. Dis. 129(Suppl.): S19-S25.
26. Reference deleted.
27. Meyer, K. F. 1970. Effectiveness of live or killed plague vaccines in man. Bull. W. H. O. 42:653-666.
28. Meyer, K. F., G. Smith, L. Foster, M. Brookman, and M. Sung. 1974. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs. J. Infect. Dis. 129(Suppl.):S85-S112.
29. Michiels, T., and G. Cornelis. 1988. Nucleotide sequence and transcription analysis of yop51 from Yersinia enterocolitica W22703. Microb. Pathog. 5:449-459.
30. Mudur, G. 1995. India's pneumonic plague outbreak continues to baffle. BMJ 311:706a.
31. Parkhill, J., B. W. Wren, N. R. Thomson, R. W. Titball, M. T. Holden, M. B. Prentice, M. Sebaihia, K. D. James, C. Churcher, K. L. Mungall, S. Baker, D. Basham, S. D. Bentley, K. Brooks, A. M. Cerdeno-Tarraga, T. Chillingworth, A. Cronin, R. M. Davies, P. Davis, G. Dougan, T. Feltwell, N. Hamlin, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Leather, S. Moule, P. C. Oyston, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413:523-527.
32. Reisman, R. E. 1970. Allergic reactions due to plague vaccine. J. Allergy 46:49-55.
33. Russell, P., S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg, and R. W. Titball. 1995. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551.
34. Trulzsch, K., T. Sporleder, E. I. Igwe, H. Russmann, and J. Heesemann. 2004. Contribution of the major secreted Yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72:5227-5234.
35. Wessman, G. E., D. J. Miller, and M. J. Surgalla. 1958. Toxic effect of glucose on virulent Pasteurella pestis in chemically defined media. J. Bacteriol. 76:368-375.
36. Williamson, E. D. 2001. Plague vaccine research and development. J Appl. Microbiol. 91:606-608.
37. Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball. 1997. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15:1079-1084.
38. Williamson, E. D., H. C. Flick-Smith, C. Lebutt, C. A. Rowland, S. M. Jones, E. L. Waters, R. J. Gwyther, J. Miller, P. J. Packer, and M. Irving. 2005. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73:3598-3608.